|
PRDM2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.34750000005901E-07 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.39000000030232E-07 |
| Normal-vs-Stage2 |
1.429330E-04 |
| Normal-vs-Stage3 |
2.96790000020586E-07 |
| Normal-vs-Stage4 |
1.79239999953396E-07 |
| Stage1-vs-Stage2 |
5.866200E-01 |
| Stage1-vs-Stage3 |
1.355400E-01 |
| Stage1-vs-Stage4 |
7.020200E-02 |
| Stage2-vs-Stage3 |
6.935800E-01 |
| Stage2-vs-Stage4 |
4.835400E-01 |
| Stage3-vs-Stage4 |
6.391200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.45870000026294E-07 |
| Normal-vs-AfricanAmerican |
8.456200E-03 |
| Normal-vs-Asian |
7.214800E-01 |
| Caucasian-vs-AfricanAmerican |
1.163170E-01 |
| Caucasian-vs-Asian |
4.886300E-02 |
| AfricanAmerican-vs-Asian |
3.374400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.68999999953179E-07 |
| Normal-vs-Female |
2.62719999999383E-06 |
| Male-vs-Female |
6.845000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.062700E-03 |
| Normal-vs-Age(41-60Yrs) |
1.9047999999966E-05 |
| Normal-vs-Age(61-80Yrs) |
3.24419999975234E-07 |
| Normal-vs-Age(81-100Yrs) |
1.573210E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.126200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.817400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.595400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.329950E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.871700E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.347200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
5.041400E-01 |
| Normal-vs-Grade 2 |
5.66389999999695E-05 |
| Normal-vs-Grade 3 |
3.03390002009962E-09 |
| Normal-vs-Grade 4 |
1.59793999999769E-05 |
| Grade 1-vs-Grade 2 |
1.845180E-01 |
| Grade 1-vs-Grade 3 |
4.812800E-04 |
| Grade 1-vs-Grade 4 |
2.673800E-02 |
| Grade 2-vs-Grade 3 |
7.81300000000096E-05 |
| Grade 2-vs-Grade 4 |
1.665400E-01 |
| Grade 3-vs-Grade 4 |
7.788400E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
5.4629000001416E-07 |
| Normal-vs-ccB subtype |
4.17369999999861E-05 |
| ccA subtype-vs-ccB subtype |
1.621570E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.27460000021973E-07 |
| Normal-vs-N1 |
4.081100E-03 |
| N0-vs-N1 |
5.663400E-01 |
|
|
